Ibrutinib reduces obinutuzumab infusion-related reactions in patients with chronic lymphocytic leukemia and is associated with changes in plasma cytokine levels

Juliana Vélez Luján, Paula A. Lengerke-Diaz, C Jacobs, Eider Moreno-Cortes, César Augusto Ramírez, Michael Y. Choi, Colin McCarthy, Alaina Heinen, Thomas J. Kipps, Januario E. Castro

Haematologica · 2019 · 15 citations · 9 references

DOIFull text

Open access

Concepts

References

9